Riverview Trust Company’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.7K Hold
104
0.03% 135
2025
Q4
$26.1K Hold
104
0.03% 149
2025
Q3
$29.9K Hold
104
0.04% 145
2025
Q2
$27.3K Sell
104
-62
-37% -$15.1K 0.03% 159
2025
Q1
$38.6K Hold
166
0.04% 261
2024
Q4
$38.1K Sell
166
-3
-2% -$688 0.03% 264
2024
Q3
$37.8K Buy
169
+107
+173% +$23.5K 0.03% 284
2024
Q2
$12.6K Hold
62
0.01% 592
2024
Q1
$13.5K Buy
+62
New +$13.7K 0.01% 608
2023
Q4
Sell
-62
Closed -$12.5K 393
2023
Q3
$12.5K Sell
62
-10
-14% -$2.11K 0.01% 627
2023
Q2
$15K Sell
72
-394
-85% -$76.4K 0.01% 522
2023
Q1
$91.8K Sell
466
-465
-50% -$95.7K 0.08% 147
2022
Q4
$188K Sell
931
-62
-6% -$12.1K 0.18% 94
2022
Q3
$175K Buy
993
+62
+7% +$12.7K 0.17% 100
2022
Q2
$187K Buy
931
+836
+880% +$178K 0.16% 102
2022
Q1
$22K Buy
+95
New +$22.3K 0.02% 453

Other funds holding LH

Riverview Trust Company's LH Position: Q1 2026 in Review

Riverview Trust Company held its Labcorp (LH) position steady in Q1 2026 at 104 shares worth $27.7K. The position accounts for 0.03% of the portfolio, ranked #135.

Riverview Trust Company first reported a position in LH in Q1 2022 and has held it in 16 quarters since. The position peaked at $188K in Q4 2022. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Riverview Trust Company held 104 shares of Labcorp worth $27.7K as of Q1 2026.
  • Riverview Trust Company left its Labcorp share count unchanged in Q1 2026.
  • Labcorp made up 0.03% of Riverview Trust Company's portfolio in Q1 2026, its #135 holding.
  • Riverview Trust Company first reported a position in Labcorp in Q1 2022 and has held it in 16 quarters since.
  • Riverview Trust Company's Labcorp position peaked at $188K in Q4 2022.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Riverview Trust Company's 13F filing for Q1 2026, filed 1 May 2026.